Virtu KCG Holdings’s Purple Biotech PPBT Stock Holding History

Virtu KCG Holdings’s Portfolio PPBT Stock Details PPBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$21K	Sell	7 -4	-36%	-$14.6K	﹤0.01%	2720
2017 Q1	$41K	Buy	+11	New	+$52.6K	﹤0.01%	2876
2016 Q4	–	Sell	-17	Closed	-$115K	–	3706
2016 Q3	$115K	Buy	17 +2	+13%	+$12.5K	﹤0.01%	2593
2016 Q2	$93K	Buy	+15	New	+$150K	﹤0.01%	2553

Other funds holding PPBT

Menta Capital San Francisco, California $236M AUM 6.6% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu KCG Holdings's PPBT Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Purple Biotech (PPBT) stake by 36% in Q2 2017, selling an estimated $14.6K and leaving 7 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #2720.

Virtu KCG Holdings first reported a position in PPBT in Q2 2016 and has held it in 4 quarters since. The position peaked at $115K in Q3 2016. 7 funds tracked by Wall St. Rank hold PPBT as of Q2 2017.

Virtu KCG Holdings held 7 shares of Purple Biotech worth $21K as of Q2 2017.
Virtu KCG Holdings sold 4 Purple Biotech shares in Q2 2017, an estimated $14.6K.
Purple Biotech made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2720 holding.
Virtu KCG Holdings first reported a position in Purple Biotech in Q2 2016 and has held it in 4 quarters since.
Virtu KCG Holdings's Purple Biotech position peaked at $115K in Q3 2016.
7 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.